A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer

ClinicalTrials.gov ID: NCT06319820

Public ClinicalTrials.gov record NCT06319820. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 10, 2026, 4:20 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized Study Evaluating the Efficacy and Safety of TAR-210 Erdafitinib Intravesical Delivery System Versus Single Agent Intravesical Chemotherapy in Participants With Intermediate-risk Non-muscle Invasive Bladder Cancer (IR-NMIBC) and Susceptible FGFR Alterations

Study identification

NCT ID: NCT06319820
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 3
Lead sponsor: Janssen Research & Development, LLC; Industry
Enrollment: 641 participants

Conditions and interventions

Conditions

Non-Muscle Invasive Bladder Neoplasms

Interventions

Gemcitabine Drug
MMC Drug
TAR-210 Combination Product

Drug · Combination Product

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Apr 17, 2024
Primary completion: Jun 27, 2028
Completion: Dec 30, 2032
Last update posted: May 7, 2026

2024 – 2032

United States locations

U.S. sites: 38
U.S. states: 21
U.S. cities: 34

Facility	City	State	ZIP	Site status
Arkansas Urology	Little Rock	Arkansas	72211	Completed
Genesis Research LLC	Los Alamitos	California	90720	Active, not recruiting
USC Norris Comprehensive Cancer Center	Los Angeles	California	90033	Active, not recruiting
University of California Irvine Medical Center	Orange	California	92868	Active, not recruiting
Om Research LLC	San Diego	California	92123	Active, not recruiting
Genesis Research LLC 1	Sherman Oaks	California	91411	Completed
University of Colorado Cancer Center Anschultz Cancer Pavilion	Aurora	Colorado	80045	Completed
Colorado Clinical Research	Lakewood	Colorado	80228	Active, not recruiting
Moffitt Cancer Center	Tampa	Florida	33612	Active, not recruiting
Northwestern University	Chicago	Illinois	60611	Completed
First Urology	Jeffersonville	Indiana	47130	Completed
Wichita Urology Group	Wichita	Kansas	67226	Active, not recruiting
Ochsner Health System	New Orleans	Louisiana	70121-2429	Active, not recruiting
Chesapeake Urology Research Associates	Hanover	Maryland	21076	Completed
Brigham And Women's Hospital	Boston	Massachusetts	02115	Completed
Karmanos Cancer Institute	Detroit	Michigan	48201	Active, not recruiting
Comprehensive Urology	Royal Oak	Michigan	48073	Active, not recruiting
Mercy Research	St Louis	Missouri	63141	Completed
Specialty Clinical Research of St Louis	St Louis	Missouri	63141	Active, not recruiting
The Urology Center, PC	Omaha	Nebraska	68114	Active, not recruiting
Cancer Institute Of New Jersey	New Brunswick	New Jersey	08901	Active, not recruiting
Integrated Medical Professionals	New York	New York	10016	Completed
Memorial Sloan Kettering Cancer Center	New York	New York	10065	Active, not recruiting
Associated Medical Professionals of Ny	Syracuse	New York	13210	Active, not recruiting
SUNY Upstate Med Univ	Syracuse	New York	13210	Active, not recruiting
Levine Cancer Institute	Charlotte	North Carolina	28204	Active, not recruiting
Associated Urologists of North Carolina	Raleigh	North Carolina	27612	Active, not recruiting
MidLantic Urology	Bala-Cynwyd	Pennsylvania	19004	Active, not recruiting
Keystone Urology Specialists	Lancaster	Pennsylvania	17604	Active, not recruiting
Carolina Urologic Research Center	Myrtle Beach	South Carolina	29572	Active, not recruiting
The Conrad Pearson Clinic	Germantown	Tennessee	38138	Active, not recruiting
University of Tennessee Medical Center	Knoxville	Tennessee	37920	Completed
Urology Associates	Nashville	Tennessee	37209	Active, not recruiting
Urology Austin	Austin	Texas	78745	Active, not recruiting
Urology Clinics of North Texas	Dallas	Texas	75231	Active, not recruiting
UT Southwestern	Dallas	Texas	75390	Completed
Houston Metro Urology	Houston	Texas	77027	Active, not recruiting
Spokane Urology	Spokane	Washington	99202	Active, not recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 155 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06319820, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted May 7, 2026 · Synced May 10, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06319820 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →